Aditxt Inc. (NASDAQ: ADTX), a social innovation platform accelerating health innovations, announced it will implement a 1-for-27 reverse stock split of its common stock, effective at the opening of trading on the Nasdaq Capital Market on May 18, 2026. The reverse split is intended to bring the company into compliance with Nasdaq's minimum bid price requirement, reducing outstanding common shares from approximately 13.8 million to about 510,123, with the stock continuing to trade under the symbol ADTX.
The move comes as a strategic step to maintain its listing on the Nasdaq exchange, which requires a minimum bid price of $1.00 per share. By reducing the number of shares outstanding, the company aims to increase the per-share price proportionally. This action is common among small-cap companies that face delisting risks due to low stock prices. Aditxt's stock has faced downward pressure in recent months, and the reverse split is designed to attract institutional investors who often avoid stocks trading below certain thresholds.
Aditxt operates a unique model that democratizes innovation, ensuring every stakeholder's voice is heard and valued. The company currently operates four programs focused on autoimmunity, cancer and early disease detection, infectious diseases and women's health. The reverse split does not change the underlying value of the company or the proportional ownership of shareholders, though it may impact liquidity and trading dynamics.
Investors should note that reverse stock splits can sometimes be perceived negatively, as they may signal financial distress. However, for Aditxt, this is a necessary compliance measure to continue trading on a major exchange. The company's ability to execute its business strategy remains unchanged.
For more details, readers can view the full press release at https://ibn.fm/S1uMK. The latest news and updates relating to ADTX are available in the company's newsroom at https://ibn.fm/ADTX.
